VenlafaxineLoperamideprophylaxisRadiationtherapyPertuzumabEverymonthIntermediate(11-25)TDM-1(Ado-trastuzumabemtansine)PembrolizumabOlaparib2years10yearsAnthracyclinesExemestaneLVEFmonitoringTaxanesTC (docetaxel /cyclophosphamide)TNBCPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)AromataseinhibitorsChemoendocrinetherapyAbemaciclibTamoxifen1yearCapecitabineVenlafaxineLoperamideprophylaxisRadiationtherapyPertuzumabEverymonthIntermediate(11-25)TDM-1(Ado-trastuzumabemtansine)PembrolizumabOlaparib2years10yearsAnthracyclinesExemestaneLVEFmonitoringTaxanesTC (docetaxel /cyclophosphamide)TNBCPercentageneeded to beconsidered HR+(adjuvantendocrine therapyconsidered)AromataseinhibitorsChemoendocrinetherapyAbemaciclibTamoxifen1yearCapecitabine

Early-Stage Breast Cancer - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Venlafaxine
  2. Loperamide prophylaxis
  3. Radiation therapy
  4. Pertuzumab
  5. Every month
  6. Intermediate (11-25)
  7. TDM-1 (Ado-trastuzumab emtansine)
  8. Pembrolizumab
  9. Olaparib
  10. 2 years
  11. 10 years
  12. Anthracyclines
  13. Exemestane
  14. LVEF monitoring
  15. Taxanes
  16. TC (docetaxel / cyclophosphamide)
  17. TNBC
  18. Percentage needed to be considered HR+ (adjuvant endocrine therapy considered)
  19. Aromatase inhibitors
  20. Chemoendocrine therapy
  21. Abemaciclib
  22. Tamoxifen
  23. 1 year
  24. Capecitabine